115 results
SC TO-T
EX-99
Corerx Inc
11 Mar 24
Third party tender offer statement
4:05pm
”) with capabilities spanning pre-investigational new drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms … -to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global
8-K
EX-99.2
SCTL
Societal CDMO Inc
28 Feb 24
Form of Tender and Support Agreement
4:58pm
an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging
CoreRx … manufacturing, and a range of packaging services. The prospects for this combined entity to establish itself as a preferred CDMO partner in the small molecule
8-K
EX-99.2
3y445jm9hh6w1cp
8 Nov 23
Societal CDMO Reports Third Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
lp6dtg7e5 wi3p5
8 Nov 23
Societal CDMO Reports Third Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
3zq8rr0
20 Sep 23
Societal CDMO announces corporate restructuring
4:10pm
424B5
hhd ajfwbw9n
25 Aug 23
Prospectus supplement for primary offering
8:06pm
424B5
kar73wkgqw8
23 Aug 23
Prospectus supplement for primary offering
4:38pm
8-K
EX-99.2
tgur7mnoq04wkr4uaibh
14 Aug 23
Societal CDMO Reports Second Quarter 2023 Financial Results
4:28pm
8-K
EX-99.1
cp2sh8ao
14 Aug 23
Societal CDMO Reports Second Quarter 2023 Financial Results
4:28pm
8-K
EX-99.2
nbxrnyz1a9cni1fru7
10 May 23
Societal CDMO Reports First Quarter 2023 Financial Results
4:22pm
8-K
EX-99.1
4lliawh zg1nziksux2i
10 May 23
Societal CDMO Reports First Quarter 2023 Financial Results
4:22pm
424B5
39bhnvzfi187v sw9yg
13 Dec 22
Prospectus supplement for primary offering
5:29pm
424B5
2wnu6p ol
13 Dec 22
Prospectus supplement for primary offering
5:26pm
424B5
lkv19dej9tzm7ijl8ta3
12 Dec 22
Prospectus supplement for primary offering
7:16am